Health · Medical Research · 4 hrs ago
N-acetylcysteine May Affect Brain Measures in Multiple Sclerosis
A small randomized trial tested N-acetylcysteine in people with multiple sclerosis, or MS. N-acetylcysteine, also called NAC, is an antioxidant treatment.
Researchers observed changes in brain connectivity among people who received NAC.
The study also found changes in cerebral glucose metabolism, the brain’s use of glucose.
These findings suggest NAC may affect brain measures in people with MS, but the trial was small.
The study does not establish what these changes mean or whether NAC improves health.
A small randomized trial suggested that N-acetylcysteine treatment led to changes in people with multiple sclerosis.
The reported changes involved functional connectivity and cerebral glucose metabolism.
The study aimed to assess oxidative stress.
The article does not provide further trial details in the available text.
- Who
- People with multiple sclerosis who took part in the trial.
- What
- N-acetylcysteine treatment was associated with changes in functional connectivity and cerebral glucose metabolism.
- When
- Not stated.
- Where
- Not stated.
- Why
- The study aimed to assess oxidative stress.
This story does not have two clearly opposing sides.
This story does not have a timeline yet.
- Treatment
- N-acetylcysteine
- Study design
- Small randomized trial
- Participants
- People with multiple sclerosis
- Measures
- Functional connectivity and cerebral glucose metabolism










